SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-15-013400
Filing Date
2015-03-02
Accepted
2015-03-02 17:25:03
Documents
2
Group Members
FCPI INNOVEN CAPITALFCPI INNOVEN CAPITAL 2FCPI INNOVEN EUROPEFCPI INNOVEN EUROPE 2FCPI INNOVEN EUROPE 3FCPI LA BANQUE POSTALE INNOVATION 1FCPI POSTE INNOVATIONFCPI POSTE INNOVATION 2FCPI POSTE INNOVATION 3FCPI POSTE INNOVATION 5FCPI POSTE INNOVATION 6FCPI

Document Format Files

Seq Description Document Type Size
1 SC 13D v403358_sc13d.htm SC 13D 267745
2 EXHIBIT 1 v403358_ex1.htm EX-1 29823
  Complete submission text file 0001144204-15-013400.txt   299741
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Subject) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88748 | Film No.: 15666062
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BURNS & LEVINSON LLP 125 SUMMER STREET BOSTON MA 02110
Business Address C/O BURNS & LEVINSON LLP 125 SUMMER STREET BOSTON MA 02110 617-345-3000
IPSA (INNOVEN PARTENAIRES S.A.) (Filed by) CIK: 0001620376 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D